Antibody-mediated rejection and aHUS in renal graft recipient

References

• Artz, M. A., Steenbergen, E. J., Hoitsma, A. J., Monnens, L. A., & Wetzels, J. F. (2003). Renal transplantation in patients with hemolytic uremic syndrome: High rate of recurrence and increased incidence of acute rejections. Transplantation, 76, 821–826.10.1097/01.TP.0000085083.74065.1B
   Google Scholar
• Barisoni, L., Schnaper, H. W., & Kopp, J. B. (2007). A proposed taxonomy for the podocytopathies: A reassessment of the primary nephrotic diseases. Clinical Journal of the American Society of Nephrology, 2, 529–542.10.2215/CJN.04121206
   Google Scholar
• Bresin, E., Daina, E., Noris, M., Castelletti, F., Stefanov, R., Hill, P., ... Remuzzi, G. (2006). Outcome of renal transplantation in patients with non-shiga-toxin associated hemolytic syndrome: prognostic significance of genetic background. Clinical Journal of the American Society of Nephrology, 1, 88–99.
   Google Scholar
• Broeders, E. N., Stordeur, P., Rorive, S., & Dahan, K. (2014). A ‘silent’, new polymorphism of factor H and apparent de novo atypical haemolytic uraemic syndrome after kidney transplantation. BMJ Case Rep, 2014, 23.
   Google Scholar
• Chandran, S., Baxter-Lowe, L., Olson, J. L., Tomlanovich, S. J., & Webber, A. (2011). Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation—A case report. Transplantation Proceedings, 43, 2097–2101.10.1016/j.transproceed.2011.02.064
   Google Scholar
• Everly, M. J., Everly, J. J., Susskind, B., Brailey, P., Arend, L. J., Alloway, R. R., ... Woodle, E. S. (2008). Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection. Transplantation, 86, 1754–1761.10.1097/TP.0b013e318190af83
   Google Scholar
• Karthikeyan, V., Parasuraman, R., Shah, V., Vera, E., & Venkat, K. K. (2003). Outcome of plasma exchange therapy in thrombotic microangiopathy after renal transplantation. American Journal of Transplantation, 3, 1289–1294.10.1046/j.1600-6143.2003.00222.x
   Google Scholar
• Le Quintrec, M., Lionet, A., Kamar, N., Karras, A., Barbier, S., Buchler, M., ... Frémeaux-Bacchi, V. (2008). Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. American Journal of Transplantation, 8, 1694–1701.10.1111/ajt.2008.8.issue-8
   Google Scholar
• Locke, J. E., Magro, C. M., Singer, A. L., Segev, D. L., Haas, M., Hillel, A. T., ... Montgomery, R. A. (2009). The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. American Journal of Transplantation, 9, 231–235.
   Google Scholar
• Lucas, J. G., Co, J. P., Nwaogwugwu, U. T., Dosani, I., & Sureshkumar, K. K. (2011). Antibody-mediated rejection in kidney transplantation: An update. Expert Opinion on Pharmacotherapy, 12, 579–592.10.1517/14656566.2011.525219
   Google Scholar
• Manenti, L., Gnappi, E., Vaglio, A., Allegri, L., Noris, M., Bresin, E., ... Buzio, C. (2013). Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature. Nephrology Dialysis Transplantation, 28, 2246–2259.10.1093/ndt/gft220
   Google Scholar
• Murer, L., Zacchello, G., Bianchi, D., Dall’Amico, R., Montini, G., Andreetta, B., ... Zacchello, F. (2000). Thrombotic microangiopathy associated with parvovirus B19 infection after renal transplantation. Journal of the American Society of Nephrology, 11, 1132–1137.
   Google Scholar
• Noone, D., Al-Matrafi, J., Tinckam, K., Zipfel, P. F., Herzenberg, A. M., Thorner, P. S., ... Licht, C. (2012). Antibody mediated rejection associated with complement factor H-related protein 3/1 deficiency successfully treated with eculizumab. American Journal of Transplantation, 12, 2546–2553.10.1111/ajt.2012.12.issue-9
   Google Scholar
• Noris, M., & Remuzzi, G. (2010). Thrombotic microangiopathy after kidney transplantation. American Journal of Transplantation, 10, 1517–1523.10.1111/ajt.2010.10.issue-7
   Google Scholar
• Pham, P. T., Peng, A., Wilkinson, A. H., Gritsch, H. A., Lassman, C., Pham, P. C., & Danovitch, G. M. (2000). Cyclosporine and tacrolimus associated thrombotic microangiopathy. American Journal of Kidney Diseases, 36, 844–850.10.1053/ajkd.2000.17690
   Google Scholar
• Polito, M. G., & Kirsztajn, G. M. (2010). Thrombotic microangiopathies: Thrombotic thrombocytopenia purpura / hemolytic uremic syndrome. Brazilian Journal of Nephrology, 32, 303–315.10.1590/S0101-28002010000300013
   Google Scholar
• Robson, M., Cote, I., Abbs, I., Koffman, G., & Goldsmith, D. (2003). Thrombotic micro-angiopathy with sirolimus-based immunosuppression: potentiation of calcineurin-inhibitor-induced endothelial damage? American Journal of Transplantation, 3, 324–327.10.1034/j.1600-6143.2003.00051.x
   Google Scholar
• Ruggenenti, P. (2002). Post-transplant hemolytic–uremic syndrome. Kidney International, 62, 1093–1104.10.1046/j.1523-1755.2002.00543.x
   Google Scholar
• Satoskar, A. A., Pelletier, R., Adams, P., Nadasdy, G. M., Brodsky, S., Pesavento, T., ... Nadasdy, T. (2010). De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection. American Journal of Transplantation, 10, 1804–1811.10.1111/ajt.2010.10.issue-8
   Google Scholar
• Schwimmer, J., Nadasdy, T. A., Spitalnik, P. F., Kaplan, K. L., & Zand, M. S. (2003). De novo thrombotic microangiopathy in renal transplant recipients: A comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy. American Journal of Kidney Diseases, 41, 471–479.10.1053/ajkd.2003.50058
   Google Scholar
• Vergoulas, G. V. (2006). Hemolytic uremic syndrome after renal transplantation. Hippokratia, 10, 99–104.
   Google Scholar
• Waiser, J., Budde, K., Rudolph, B., Ortner, M. A., & Neumayer, H. H. (1999). De novo hemolytic uremic syndrome postrenal transplant after cytomegalovirus infection. American Journal of Kidney Diseases, 34, 556–559.10.1016/S0272-6386(99)70085-5
   Google Scholar
• Zarifian, A., Meleg-Smith, S., O’Donovan, R., Tesi, R. J., & Batuman, V. (1999). Cyclosporine-associated thrombotic microangiopathy in renal allografts. Kidney International, 55, 2457–2466.10.1046/j.1523-1755.1999.00492.x
   Google Scholar
• Zuber, J., Le Quintrec, M., Krid, S., Bertoye, C., Gueutin, V., Lahoche, A., ... French Study Group for Atypical HUS. (2012). Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation. American Journal of Transplantation, 12, 3337–3354.10.1111/ajt.2012.12.issue-12
   Google Scholar
• Zuber, J., Le Quintrec, M., Morris, H., Frémeaux-Bacchi, V., Loirat, C., & Legendre, C. (2013). Targeted strategies in the prevention and management of atypical HUS recurrence after kidney transplantation. Transplantation Reviews, 27, 117–125.10.1016/j.trre.2013.07.003
   Google Scholar
• Zuber, J., Le Quintrec, M., Sberro-Soussan, R., Loirat, C., Frémeaux-Bacchi, V., & Legendre, C. (2011). New insights into postrenal transplant hemolytic uremic syndrome. Nature Reviews Nephrology, 7, 23–35.10.1038/nrneph.2010.155
   Google Scholar